People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kindred Biosciences, Inc. | — | Biotechnology | Series A | $14.8M | $192.0M | 2013 |
| Hilltop Biosciences Inc. | — | Biotechnology | Series A | $7.8M | $22.8M | 2020 |
| Vetmab Biosciences, Inc. | — | Biotechnology | Seed | $2.6M | $3.9M | 2023 |
Denise Bevers at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Denise Bevers on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Chin | 2 | 4 |
| Mark Williams | 1 | 12 |
| Ernest Mario | 1 | 9 |
| Jessica McLear | 1 | 3 |
| Alan Watson | 1 | 2 |
| Jill Wittels | 1 | 1 |
| Hangjun Zhan | 1 | 1 |
| Hangjun Marie Zhan | 1 | 1 |
| Richard Marie Chin | 1 | 1 |
| Denise Marie Bevers | 1 | 1 |
| Ervin Vezspremi | 1 | 1 |
| Stephen Sundlof | 1 | 1 |
| Amanda Drobnis | 1 | 1 |
| Denise Beavers | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.